by James Le Fanu. BMJ 2018;361:k2794 (June 28, 2018)
Profligate prescribing has brought a hidden epidemic of side
effects and no benefit to most individuals.
[All of us who drift into physicians’ offices are subject to
over-medicalization by overworked, ignorant, well-meaning, but often autocratic, physicians. DJE]
Excerpts:
“Tis impossible to separate the chance of good from the risk
of ill,” wrote David Hume presciently, anticipating, by 250 years, medicine’s
current existential crisis. There is no drug or procedure with its “chance of
good” that may not harm some. The more doctors do, the greater that risk. And
doctors are certainly doing much more with, over the past 20 years, a dizzying
fourfold rise in prescriptions for diabetes treatments, sevenfold for
anti-hypertensives, and 20-fold for the cholesterol lowering statins.
There is a hidden epidemic of anxiety-producing symptoms
such as fatigue,
muscular aches and pains, insomnia, and general decrepitude,
a 75% rise in emergency admissions to hospital for adverse drug reactions. Le Fanu feels that this was driven by sophistic
public health research that played into the drug industry’s goal of mass
medicalisation.
This ‘close alignment of the priorities of public health
with the marketing practices of this most profitable of industries’ has been
achieved by lowering the threshold for initiating treatment to include those
whose physiological variables are only marginally elevated, if at all. The
simple expedient of redefining diabetes, hypertension, and hypocholesteraemia
in this way increased their prevalence in the US by, respectively, 14%, 35%,
and 86% -- an additional 56 million cases, more than a third of the total adult
population of 187 million.
The population was not “sick” after all, but has certainly
been made sick by the iatrogenic consequences of that profligate prescribing.